Broadridge Financial Solutions vs Concentrix
BR and CNXC side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BR and CNXC compare
Broadridge Financial Solutions is the larger company, worth 11 times as much as Concentrix ($21.9B against $2.0B).
Broadridge Financial Solutions grew revenue faster over the last twelve months (8.5% versus 2.6% for Concentrix).
Broadridge Financial Solutions keeps more of each dollar of sales as profit, with a net margin of 15.0% compared with −24.0% at Concentrix.
Both pay dividends: Broadridge Financial Solutions yields 2.1% and Concentrix 4.4%.
Broadridge Financial Solutions scores higher on the StockData Score (22 against 8 for Concentrix), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BR | CNXC |
|---|---|---|
| Size and price | ||
| Market cap | $21.9B | $2.0B |
| Share price | $192.45 | $32.72 |
| Change, 1 year | −14.0% | −7.4% |
| Change, 5 years | 10.5% | −82.4% |
| Beta (5Y) | 0.81 | 1.02 |
| Employees | 16K | 455K |
| StockData Score | ||
| Total score | 22 (better) | 8 |
| Valuation score | 4 (better) | 3 |
| Growth score | 3 (better) | 1 |
| Performance score | 6 (better) | 0 |
| Health score | 5 (better) | 1 |
| Dividend score | 4 (better) | 3 |
| Valuation | ||
| P/E | 20.0× | – |
| P/S | 2.9× | 0.2× (better) |
| P/B | 7.7× | 1.1× (better) |
| EV/EBITDA | 17.2× | – |
| P/FCF | 17.2× | 3.5× (better) |
| PEG | 0.92 | – |
| FCF yield | 5.8% | 28.8% (better) |
| Fair value | $233.30 | $98.17 |
| Margin of safety | 17.5% | 66.7% (better) |
| Growth | ||
| Revenue growth (TTM) | 8.5% (better) | 2.6% |
| Revenue growth, 5Y average | 8.4% | 15.8% (better) |
| Net income growth (TTM) | 33.9% (better) | −856% |
| EPS growth (TTM) | 35.2% (better) | −921% |
| EPS growth, 5Y average | 15.6% | – |
| Profitability | ||
| Gross margin | 31.8% | 34.1% (better) |
| Operating margin | 17.4% (better) | −20.9% |
| Net margin | 15.0% (better) | −24.0% |
| FCF margin | 17.1% (better) | 5.8% |
| Return on equity | 40.9% (better) | −78.2% |
| Return on invested capital | 18.6% (better) | −22.3% |
| Financial health | ||
| Debt / equity | 1.15 (better) | 2.47 |
| Net debt / EBITDA | 1.98 | – |
| Interest coverage | 11.6× | – |
| Current ratio | 1.24 (better) | 1.23 |
| Altman Z-score | 4.23 (better) | 0.39 |
| Piotroski F-score | 8 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | 2.1% | 4.4% (better) |
| Payout ratio | 39.4% | – |
| Years of dividend growth | 17 | – |
| Dividend growth, 5Y average | 11.1% | – |
| Buyback yield | 2.8% | 5.0% (better) |
| Shareholder yield | 4.8% | 9.4% (better) |
| Ownership | ||
| Held by institutions | 94.5% | 112% |
| Held by insiders | 0.44% | 13.1% |
| Insider net buying, 12 months | −$2.7M (better) | −$133M |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 3.1% | 15.1% |
Go deeper
- BR stock overview
- BR income statement
- BR valuation and score
- CNXC stock overview
- CNXC income statement
- CNXC valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.